Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 1.0. It has been cited 40 times, with 35 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.557
From this paper's citation signal
Citation Network Contribution
0.481
From 24 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 35 citers.
Ministerio de Ciencia e Innovación
Grant: SAF2017-83151-R
Ministerio de Ciencia e Innovación
Grant: Rti2018-095784b-100 SAF
National Institutes of Health
Grant: P01 NS097197
National Institutes of Health
Grant: 5P01NS097197-04
Lafora Epilepsy - Basic mechanisms to therapy
FWCI
4.01
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Genetic prediction of antihyperglycemic drug targets and risk of epilepsy: a mendelian randomisation study
Additional file 1 of Genetic prediction of antihyperglycemic drug targets and risk of epilepsy: a mendelian randomisation study